Care recommendations for patients with myotonic dystrophy

Published in 2018 is a consensus based approach for the myotonic dystrophy patient community. This gives general guidelines on how to approach, test and intervene in patients lives to achieve the most optimum outcomes.


Print Friendly, PDF & Email

Increased cancer risk for patients with myotonic dystrophy

Conclusion: Patients with myotonic dystrophy may have an increased risk of thyroid cancer and choroidal melanoma
and, possibly, testicular and prostate cancers.


Print Friendly, PDF & Email